Wefight

Wefight is an innovative health technology company focused on improving patient experiences and outcomes by providing personalized information and support for managing chronic diseases through digital platforms. Founded in 2017 in Paris, France, Wefight specializes in developing digital health solutions that enhance patient engagement. Led by CEO Benoit Brouard, the company has completed three funding deals, with the most recent investment of EUR 3 million occurring on September 19, 2022, co-led by Digital Health Ventures and MPACT partners, alongside Investir&+. With a current valuation of EUR 14.

799 mn, Wefight continues to strengthen its position in the health tech market. Wefight offers a comprehensive digital platform designed for patients dealing with chronic diseases. The platform provides tailored information and support to help users manage their health more effectively. By leveraging technology, Wefight enhances patient engagement and facilitates better communication between healthcare providers and patients, enabling a more informed and proactive approach to health management.

In the most recent year, 2022, Wefight reported a revenue of EUR 4,722,312. 10 with an EBITDA of EUR -3,819,760. 70, reflecting the company's ongoing investment in product development and market expansion. Wefight plans to leverage its recent funding of EUR 3 million to enhance its digital health platform and expand its product offerings.

The company aims to introduce new features tailored to chronic disease management by the end of 2023. Additionally, Wefight intends to explore new markets in Europe and Asia, aiming for a presence in key regions by 2024. These growth strategies will be supported by the latest funding round, which is earmarked for technology enhancement and market entry initiatives.